Harmony Biosciences Financials

Values in thousands	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	$243,776	$239,455	$200,489	$184,733
Gross Profit	175,231	179,805	162,336	152,739
EBITDA	44,306	73,458	59,250	66,981
EBIT	38,362	67,490	53,283	61,013
Net Income	22,486	50,865	39,776	45,560
Net Change In Cash	243,776	239,455	200,489	184,733
Free Cash Flow	-221,845	108,663	79,323	33,859
Cash	752,502	646,999	546,050	488,998
Basic Shares	58,696	58,717	58,427	58,524

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$868,453	$714,734	$582,022	$437,855
Gross Profit	670,111	557,919	460,786	354,374
EBITDA	229,713	233,412	221,512	146,866
EBIT	205,866	209,300	197,153	123,481
Net Income	158,687	145,493	128,853	181,468
Net Change In Cash	868,453	714,734	582,022	437,855
Cost of Revenue				9,475
Free Cash Flow	347,889	218,668	219,075	144,294
Cash	752,502	453,001	311,660	243,784
Basic Shares	58,544	57,870	60,372	61,097